Navamedic Financial Report Q2 2013

Navamedic ASA (OSE: NAVA), the Norwegian pharmaceutical products company, today announced its second quarter 2013 results.
Navamedic's income reached NOK 38.1 million in the second quarter 2013, compared to NOK 22.7 million in the same quarter last year. EBITDA ended at NOK 0.8 million in the second quarter, against NOK 0.4 million last year. Navamedic's net result for the second quarter came in at NOK -0.5 million, against NOK -0.4 million in the same quarter of 2012.
For the first half of 2013 Navamedic posted income of NOK 72.1 million, against NOK 43.3 million last year. This represents a revenue growth of 67 per cent. EBITDA for the first half was NOK 4.3 million, against 0.5 million last year. Navamedic's net profit for the first half 2013 ended at NOK 0.9 million, while the net result in last year's first half was NOK -1.4 million.

Contact Navamedic:

CEO Håkan Josephsson mob: +46 706 742 533
CFO Bjørn Lindholt mob: +47  93 00 66 01

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.